Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low-molecular-weight heparin

American Journal of Hematology

Volumn 52, Issue 2, 1996, Pages 90-95

  Amiral, Jean ^a   Peynaud Debayle, Edith ^b   Wolf, Martine ^b   Bridey, Françoise ^b,c   Vissac, Anne Marie ^a   Meyer, Dominique ^b  

^a Serbio Research Laboratory   (France)

^b Service d'Hematologie   (France)

^c BICHAT HOSPITAL   (France)

Author keywords

anti heparin PF4 autoantibodies; heparin; HIT; LMWH; platelet activation; UH

Indexed keywords

AUTOANTIBODY; HEPARIN; HEPARIN ANTIBODY; HEPARIN CALCIUM; LOW MOLECULAR WEIGHT HEPARIN; THROMBOCYTE FACTOR 4 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOCYTOPENIA;

AUTOIMMUNE DISEASES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FOLLOW-UP STUDIES; HEPARIN; HUMANS; IMMUNOGLOBULIN ISOTYPES; PLATELET FACTOR 4; THROMBOCYTOPENIA; TIME FACTORS;

EID: 0029887360     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199606)52:2<90::AID-AJH4>3.0.CO;2-0     Document Type: Article

References (24)

1. Amiral J, Bridey F, Dreyfus M, Vissac AM, Fressinaud E, Wolf M, Meyer D: Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin induced thrombocytopenia. Thromb Haemost 68:95, 1992.
2. Greinacher A, Pötzch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C: Heparin associated thrombocytopenia: Isolation of the antibody and characterization of a multimolecular pF4-Heparin complex as the major antigen. Thromb Haemost 71:247, 1994.
3. Kelton G, Smith JW, Warkentin TE, Hayward CPM, Denomme GA, Horsewood P: Immunoglobulin G from patients with heparin induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood 83:3232, 1994.
4. Visentin GP, Ford SE, Scott JP, Aster RH: Antibodies from patients with heparin induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 93:81, 1994.
5. Greinacher A, Amiral J, Dummel V, Vissac AM, Kiefel V, Mueller-Eckhardt C: Laboratory diagnosis of heparin associated thrombocytopenia and comparison of platelet aggregation test, heparin induced platelet activation test, and platelet factor 4/heparin enzyme linked immunosorbent assay. Transfusion 34:381, 1994.
6. Amiral J, Bridey F. Wolf M, Boyer-Neumann C, Fressinaud E, Vissac AM, Peynaud-Debayle E, Dreyfus M, Meyer D: Antibodies to macro-molecular platelet factor 4 heparin complexes in heparin induced thrombocytopenia: A study of 44 cases. Thromb Haemost 73:21, 1995.
7. Capitanio AM, Niewiarowski S, Rucinski B, Tuzynski GP, Cierniewski CS. Hershock D, Kornecki E: Interaction of platelet factor 4 with human platelets. Biochim Biophys Acta 839:161, 1985.
8. Warkentin TE, Levine MN, Roberts RS, Gent M, Horsewood P, Kelton JG: Heparin induced thrombocytopenia is more common with unfractionated heparin than with low molecular weight heparin. Thromb Haemost 69:911, 1993.
9. Nakane PK, Kawaoi A: Peroxidase labeled antibody: A new method of conjugation. J Histochem Cytochem 22:1084, 1974.
10. Laster J, Elfrink R, Silver D: Reexposure to heparin of patients with heparin associated antibodies. J Vasc Surg 9:677, 1989.
11. Cadroy Y, Amiral J, Raynaud H, Brunel P, Mazaleyrat A, Sauer M, Sie P: Evolution of antibodies anti-PF4/heparin in a patient with a history of heparin induced thrombocytopenia reexposed to heparin. Thromb Haemost 72:782, 1994.
12. Brace LD, Fareed J: Heparin-induced platelet aggregation: Dose/response relationships for a low molecular weight heparin derivative (PK 10169) and its subfractions. Thromb Res 42:769, 1986.
13. Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, Kelton JG: Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 332:1330, 1995.
14. Kelton JG, Sheridan D, Santos A, Smith J, Steeves K, Smith C, Brown C, Murphy WG: Heparin induced thrombocytopenia: Laboratory studies. Blood 72:925, 1988.
15. Laroche J, Clofent-Sanchez G, Jallu V, Hourdillé P, Vezon G, Nurden AT: Further evidence that heparin dependent thrombocytopenia may result from Fc receptor-mediated interactions. Nouv Rev Fr Hematol 34:111, 1992.
16. Chong BH, Pilgrim RL, Cooley MA, Chesterman CN: Increased expression of platelet IgG Fc receptors in immune heparin induced thrombocytopenia. Blood 81:988, 1993.
17. Chong BH: Heparin induced thrombocytopenia. Br J Haematol 89: 431, 1995.
18. Warkentin TE, Hayward CPM, Boshkov LK, Santos AV, Sheppard JAI, Bode AP, Kelton JG: Sera from patients with heparin induced thrombocytopenia generate platelet derived microparticles with procoagulant activity: An explanation for the thrombotic complications of heparin induced thrombocytopenia. Blood 84:3691, 1994.
19. De Reys S, Hoylaerts MF, De Ley M, Vermylen J, Deckmyn H: Fc-independent cross-linking of a novel platelet membrane protein by a monoclonal antibody causes platelet activation. Blood 84:547, 1994.
20. Mach-Wunderle V, Kainer K, Krug B, Müller-Bergbaus G, Pötzsch B: Heparin-associated thrombosis despite normal platelet counts. Lancet 344:469, 1994.
21. Visentin GP, Malik MI, Menden K, Aster RH: A prospective study of the formation of antibodies reactive with heparin: PF4 complexes in patients treated with heparin. Blood 84:80a, 1994.
22. Amiral J, Wolf M, Fischer AM, Boyer-Neumann C, Vissac AM, Meyer D: Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin induced thrombocytopenia. Br J Haematol (in press).
23. Brandt JT, Osborne JM, Chacko G, Anderson CL: The role of FcγRIIA phenotype in heparin-induced thrombocytopenia. Thromb Haemost 73: 1064, 1995.
24. Cines DB, Tomaski A, Tannenbaum S: Immune endothelial-cell injury in heparin-associated thrombocytopenia. N Engl J Med 316:581, 1987.